ea0026oc3.6 | Bone/Reproduction | ECE2011
Chevalier N
, Lelannou D
, Letur H
, Cornet D
, Chalas-Boissonas C
, Frydman R
, Ohl J
, Greck Th
, Papaxanthos-Roche A
, Dulucq M C
, Couet M L
, Cedrin-Durnerin I
, Pouly J L
, Fenichel P
Context: Recombinant human GH treatment and oocyte donation (OD) have improved the quality of life in women with Turner syndrome (TS). However, life expectancy is reduced, mainly due to cardiovascular complications. Pregnancy may itself increase that risk and be associated with hazardous materno-fetal outcome.Objective: The objective of this study was to evaluate the materno-fetal outcome of ongoing pregnancies beyond 20 weeks of gestation obtained by OD...